New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
February 2, 2023 - AstraZeneca and Amgen announced the FDA approval of Tezspire (teplizumab-ekko) solution in a single-dose pre-filled pen.
Download PDF
Return to publications
